Citigroup »

Aim Immunotech shares owned by Citigroup

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Citigroup

Quarter filed Position value Share count Share price at filing
2026-09-30 $6.5k 37k 0.18

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Citigroup

Top funds holding Aim Immunotech

Jane Street
Virtu Financial
Geode Capital Management
Citigroup
Goldman Sachs Group
UBS Group
Susquehanna International
Vanguard Fiduciary Trust
Tower Research Capital
Continuum Advisory
Community Bank
Harbour Investments
Creative Financial Designs
Advisor Group Holdings
Hoey Investments

View all funds holding Aim Immunotech